The Effect of Aerobic Exercise, on Fitness and Functional Muscle Strength, in Patients With Muscular Dystrophy
NCT01895283 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2016-04-06
Summary
Muscular dystrophy is a group of disorders that are characterized by progressive muscle weakening and loss of muscle mass, caused by defects in muscle proteins. Muscular dystrophy is almost always inherited disorders, and so far, no curative treatments exist.
Previous studies have shown that endurance training significantly improves fitness and self-assessed muscle function in a variety of muscular dystrophies. In this study, we wish to investigate whether patients with Bethlem myopathy (a specific form of muscular dystrophy) also benefit from endurance training.
The study consists of two test days, a 10-week training period and five blood tests.
Patients will be required to train, three times per week, for 10 weeks, on a bike ergometer with a specific training intensity, under pulse rate monitoring.
The training period will be flanked by two test days, where we will determine, and compare the patients' muscle strength and fitness level, from before to after the training program. The patients conditioning level will be determined from a 15 minute cycle ergometer test and patients will undergo three functional tests to determine their functional muscle strength.
We will as a safety measure analyze blood tests before, during and after the training program for the muscle enzyme creatine kinase (an indicator of muscle damage) and through adverse effects as reported by patients during weekly telephone-consultations with the Principal investigator.
We anticipate, that Bethlem myopathy patients will have a similar rise in fitness level and functional muscle strength, as that seen in patients with other forms of muscular dystrophy, who undertake a similar training program.
Conditions
- Bethlem Myopathy
Interventions
- BEHAVIORAL
-
Moderate-intensity training
Training at 70% of VO2max, for 1/2 hour, three times weekly, for 10 weeks, on a bike ergometer.
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Christoffer R Vissing, BsC · Rigshospitalet, Neuromuscular Research Unit
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 16 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2014-12-31
- Completion
- 2015-01-31
Countries
- Denmark
Study Locations
More Related Trials
-
The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease
NCT00457314 ·Status: UNKNOWN ·Phase: PHASE2
-
Calf Muscle Strength in Mitochondrial Diseases
NCT02678637 ·Status: COMPLETED
-
Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy
NCT01369901 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
NCT02972580 ·Status: ACTIVE_NOT_RECRUITING
-
Twice Weekly Steroids and Exercise as Therapy for DMD
NCT04322357 ·Status: COMPLETED ·Phase: PHASE2
-
Aerobic Exercise Training in Amyotrophic Lateral Sclerosis
NCT01650818 ·Status: UNKNOWN ·Phase: NA
-
Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy
NCT00004769 ·Status: COMPLETED
-
Breathlessness Assessment in Adult Patients With Myotonic Dystrophy Type 1
NCT04835298 ·Status: COMPLETED
-
The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD
NCT02614820 ·Status: UNKNOWN ·Phase: NA
-
Exercise Capacity of Patients with Dermatomyosis
NCT03293615 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies
NCT02109692 ·Status: UNKNOWN ·Phase: NA
-
Multicenter Observational Study of Myotonic Dystrophy Type 1
NCT02308657 ·Status: COMPLETED
-
Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)
NCT00468832 ·Status: UNKNOWN
-
Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I
NCT02165358 ·Status: COMPLETED
-
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
NCT01521728 ·Status: COMPLETED ·Phase: NA
-
Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin
NCT02516085 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy
NCT05280730 ·Status: COMPLETED
-
Schulze Muscular Dystrophy Ability Clinical Study
NCT05409079 ·Status: UNKNOWN ·Phase: NA
-
Correlation Between Functional Capacity and Functional Capability in Duchenne Muscular Dystrophy
NCT05249361 ·Status: RECRUITING
-
Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy
NCT02195999 ·Status: COMPLETED
-
Contractile Cross Sectional Areas and Muscle Strength in Patients With Congenital Myopathies
NCT03018184 ·Status: COMPLETED
-
Research of Biomarkers in Duchenne Muscular Dystrophy Patients
NCT01380964 ·Status: COMPLETED
-
Biomarker Development for Muscular Dystrophies
NCT05019625 ·Status: RECRUITING
-
Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital
NCT05029232 ·Status: UNKNOWN ·Phase: NA
-
Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography
NCT03490214 ·Status: COMPLETED ·Phase: NA